First Light Asset Management, LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
First Light Asset Management, LLC disclosed 41 US equity positions worth $1.1bn in its Q3 2025 13F filing. The largest position was AXGN at 9.8% of the reported book, followed by PFMTUSD and CNTA. Against the Q2 2025 filing, it opened 9 new positions, added to 14 and reduced 17 among the top 41 holdings.
What did First Light Asset Management, LLC own in Q3 2025? Top 41 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | AXGN AXOGEN INC | Healthcare | 9.8% | $103.6m | 5,805,730 | 28% | added |
| 2 | PFMTUSD PERFORMANT HEALTHCARE INC | 8.5% | $90.6m | 11,718,612 | -11% | reduced | |
| 3 | CNTA CENTESSA PHARMACEUTICALS LIMITED | 8.3% | $88.2m | 3,635,816 | -15% | reduced | |
| 4 | NEO NEOGENOMICS INC | Healthcare | 7.2% | $76.6m | 9,927,269 | 45% | added |
| 5 | AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 4.3% | $45.6m | 3,355,882 | – | new |
| 6 | CRNXGBP CRINETICS PHARMACEUTICALS INC | 3.7% | $39.2m | 941,516 | 9% | added | |
| 7 | HCAT HEALTH CATALYST INC | Healthcare | 3.6% | $38.3m | 13,436,220 | 10% | added |
| 8 | PVLA PALVELLA THERAPEUTICS INC | 3.2% | $33.9m | 541,544 | – | new | |
| 9 | TWST TWIST BIOSCIENCE CORPORATION | Healthcare | 3.2% | $33.6m | 1,194,883 | 26% | added |
| 10 | LENZ LENZ THERAPEUTICS INC | Healthcare | 3.0% | $32.3m | 693,044 | – | new |
| 11 | ORGO ORGANOGENESIS HOLDINGS INC | Healthcare | 3.0% | $31.6m | 7,497,911 | 11% | added |
| 12 | ATRC ATRICURE INC | Healthcare | 3.0% | $31.4m | 890,362 | -12% | reduced |
| 13 | ANAB ANAPTYS BIO INC | Healthcare | 2.9% | $30.3m | 990,161 | -72% | reduced |
| 14 | SIBN SI-BONE INC | Healthcare | 2.7% | $28.2m | 1,917,903 | 10% | added |
| 15 | CDTX CIDARA THERAPEUTICS INC | 2.6% | $28.0m | 292,657 | 62% | added | |
| 16 | IRTC IRHYTHM TECHNOLOGIES | Healthcare | 2.5% | $26.7m | 155,099 | -17% | reduced |
| 17 | MDXG MIMEDX GROUP INC | Healthcare | 2.4% | $25.5m | 3,652,952 | 90% | added |
| 18 | EWTX EDGEWISE THERAPEUTICS INC | 2.2% | $23.0m | 1,414,994 | -17% | reduced | |
| 19 | MASS 908 DEVICES INC | 2.1% | $22.0m | 2,510,496 | 135% | added | |
| 20 | MERUS NV | 2.0% | $21.1m | 224,080 | – | new | |
| 21 | RYTM RHYTHM PHARMACEUTICALS INC | Healthcare | 1.7% | $18.2m | 180,484 | – | new |
| 22 | GH GUARDANT HEALTH | Healthcare | 1.6% | $17.5m | 280,001 | 117% | added |
| 23 | KRMD KORU MEDICAL SYSTEMS INC | 1.6% | $17.3m | 4,527,737 | -3% | reduced | |
| 24 | ESTA ESTABLISHMENT LABS HOLDINGS | Healthcare | 1.6% | $17.1m | 418,358 | 0% | held |
| 25 | ADMA ADMA BIOLOGICS INC | Healthcare | 1.5% | $15.7m | 1,069,233 | 12% | added |
| 26 | IRON DISC MEDICINE INC | Healthcare | 1.4% | $15.3m | 231,186 | – | new |
| 27 | VERA VERA THERAPEUTICS INC | Healthcare | 1.4% | $14.7m | 507,097 | -10% | reduced |
| 28 | NPCE NEUROPACE INC | 1.3% | $14.0m | 1,360,071 | -1% | reduced | |
| 29 | CAI CARIS LIFE SCIENCES INC | Healthcare | 1.1% | $11.9m | 403,924 | -9% | reduced |
| 30 | SLP SIMULATIONS PLUS INC | Healthcare | 1.1% | $11.6m | 767,760 | 115% | added |
| 31 | RARE ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.8% | $8.6m | 285,699 | -48% | reduced |
| 32 | ABVX ABIVAX SA-ADR | 0.8% | $8.1m | 95,955 | – | new | |
| 33 | SENS SENSEONICS HOLDINGS INC | Healthcare | 0.7% | $7.8m | 18,007,632 | -50% | reduced |
| 34 | RGEN REPLIGEN CORP | Healthcare | 0.5% | $5.5m | 41,427 | -6% | reduced |
| 35 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 0.5% | $5.5m | 197,350 | 61% | added |
| 36 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.5% | $5.3m | 11,539 | – | new |
| 37 | EVH EVOLENT HEALTH INC | Healthcare | 0.4% | $4.6m | 545,282 | -26% | reduced |
| 38 | ALHC ALIGNMENT HEALTHCARE INC | Healthcare | 0.3% | $3.5m | 203,138 | -47% | reduced |
| 39 | RDNT RADNET INC | Healthcare | 0.3% | $3.2m | 42,280 | -38% | reduced |
| 40 | TECX TECTONIC THERAPEUTICS INC | Healthcare | 0.3% | $3.2m | 202,393 | – | new |
| 41 | BFLY BUTTERFLY NETWORK INC | 0.2% | $2.2m | 1,127,998 | -79% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.